Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues.
We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.
Total Funding: $2,200,000
Funding Stage: Series A
Business Stage: N/A
Market: N/A
Company Size: 26 to 50
Founded: 2015
